##gff-version 3
##sequence-region Q9BR39 1 696
Q9BR39	UniProtKB	Chain	1	696	.	.	.	ID=PRO_0000159847;Note=Junctophilin-2	
Q9BR39	UniProtKB	Chain	1	572	.	.	.	ID=PRO_0000446375;Note=Junctophilin-2 N-terminal fragment;Ontology_term=ECO:0000250;evidence=ECO:0000250|UniProtKB:Q9ET78	
Q9BR39	UniProtKB	Topological domain	1	674	.	.	.	Note=Cytoplasmic;Ontology_term=ECO:0000255;evidence=ECO:0000255	
Q9BR39	UniProtKB	Transmembrane	675	695	.	.	.	Note=Helical%3B Anchor for type IV membrane protein;Ontology_term=ECO:0000255;evidence=ECO:0000255	
Q9BR39	UniProtKB	Repeat	14	36	.	.	.	Note=MORN 1;Ontology_term=ECO:0000255;evidence=ECO:0000255	
Q9BR39	UniProtKB	Repeat	38	59	.	.	.	Note=MORN 2;Ontology_term=ECO:0000255;evidence=ECO:0000255	
Q9BR39	UniProtKB	Repeat	60	79	.	.	.	Note=MORN 3;Ontology_term=ECO:0000255;evidence=ECO:0000255	
Q9BR39	UniProtKB	Repeat	82	104	.	.	.	Note=MORN 4;Ontology_term=ECO:0000255;evidence=ECO:0000255	
Q9BR39	UniProtKB	Repeat	106	128	.	.	.	Note=MORN 5;Ontology_term=ECO:0000255;evidence=ECO:0000255	
Q9BR39	UniProtKB	Repeat	129	151	.	.	.	Note=MORN 6;Ontology_term=ECO:0000255;evidence=ECO:0000255	
Q9BR39	UniProtKB	Repeat	291	313	.	.	.	Note=MORN 7;Ontology_term=ECO:0000255;evidence=ECO:0000255	
Q9BR39	UniProtKB	Repeat	314	336	.	.	.	Note=MORN 8;Ontology_term=ECO:0000255;evidence=ECO:0000255	
Q9BR39	UniProtKB	Motif	351	365	.	.	.	Note=Bipartite nuclear localization signal;Ontology_term=ECO:0000250;evidence=ECO:0000250|UniProtKB:Q9ET78	
Q9BR39	UniProtKB	Motif	495	499	.	.	.	Note=Nuclear localization signal;Ontology_term=ECO:0000250;evidence=ECO:0000250|UniProtKB:Q9ET78	
Q9BR39	UniProtKB	Compositional bias	3	142	.	.	.	Note=Gly-rich	
Q9BR39	UniProtKB	Compositional bias	373	408	.	.	.	Note=Ala-rich	
Q9BR39	UniProtKB	Compositional bias	452	633	.	.	.	Note=Pro-rich	
Q9BR39	UniProtKB	Site	155	156	.	.	.	Note=Cleavage%3B by calpain;Ontology_term=ECO:0000250;evidence=ECO:0000250|UniProtKB:Q9ET78	
Q9BR39	UniProtKB	Site	204	205	.	.	.	Note=Cleavage%3B by calpain;Ontology_term=ECO:0000250;evidence=ECO:0000250|UniProtKB:Q9ET78	
Q9BR39	UniProtKB	Site	572	573	.	.	.	Note=Cleavage%3B by calpain;Ontology_term=ECO:0000250;evidence=ECO:0000250|UniProtKB:Q9ET78	
Q9BR39	UniProtKB	Modified residue	162	162	.	.	.	Note=Phosphoserine;Ontology_term=ECO:0000250;evidence=ECO:0000250|UniProtKB:Q2PS20	
Q9BR39	UniProtKB	Modified residue	165	165	.	.	.	Note=Phosphoserine;Ontology_term=ECO:0000269;evidence=ECO:0000269|PubMed:20095964;Dbxref=PMID:20095964	
Q9BR39	UniProtKB	Modified residue	446	446	.	.	.	Note=Phosphoserine;Ontology_term=ECO:0000250;evidence=ECO:0000250|UniProtKB:Q2PS20	
Q9BR39	UniProtKB	Modified residue	448	448	.	.	.	Note=Phosphoserine;Ontology_term=ECO:0000250;evidence=ECO:0000250|UniProtKB:Q2PS20	
Q9BR39	UniProtKB	Modified residue	469	469	.	.	.	Note=Phosphoserine;Ontology_term=ECO:0000244;evidence=ECO:0000244|PubMed:17081983;Dbxref=PMID:17081983	
Q9BR39	UniProtKB	Modified residue	477	477	.	.	.	Note=Phosphothreonine;Ontology_term=ECO:0000250;evidence=ECO:0000250|UniProtKB:Q9ET78	
Q9BR39	UniProtKB	Modified residue	484	484	.	.	.	Note=Phosphoserine;Ontology_term=ECO:0000244;evidence=ECO:0000244|PubMed:18669648;Dbxref=PMID:18669648	
Q9BR39	UniProtKB	Modified residue	486	486	.	.	.	Note=Phosphoserine;Ontology_term=ECO:0000244;evidence=ECO:0000244|PubMed:18669648;Dbxref=PMID:18669648	
Q9BR39	UniProtKB	Modified residue	490	490	.	.	.	Note=Phosphothreonine;Ontology_term=ECO:0000244,ECO:0000244;evidence=ECO:0000244|PubMed:18669648,ECO:0000244|PubMed:24275569;Dbxref=PMID:18669648,PMID:24275569	
Q9BR39	UniProtKB	Modified residue	534	534	.	.	.	Note=Phosphoserine;Ontology_term=ECO:0000250;evidence=ECO:0000250|UniProtKB:Q2PS20	
Q9BR39	UniProtKB	Modified residue	594	594	.	.	.	Note=Phosphoserine;Ontology_term=ECO:0000250;evidence=ECO:0000250|UniProtKB:Q9ET78	
Q9BR39	UniProtKB	Modified residue	598	598	.	.	.	Note=Phosphoserine;Ontology_term=ECO:0000250;evidence=ECO:0000250|UniProtKB:Q9ET78	
Q9BR39	UniProtKB	Alternative sequence	128	129	.	.	.	ID=VSP_002785;Note=In isoform 2. TY->MC;Ontology_term=ECO:0000303;evidence=ECO:0000303|Ref.1	
Q9BR39	UniProtKB	Alternative sequence	130	696	.	.	.	ID=VSP_002786;Note=In isoform 2. Missing;Ontology_term=ECO:0000303;evidence=ECO:0000303|Ref.1	
Q9BR39	UniProtKB	Natural variant	85	85	.	.	.	ID=VAR_081287;Note=Probable disease-associated mutation found in a patient with dilated cardiomyopathy. E->K;Ontology_term=ECO:0000269;evidence=ECO:0000269|PubMed:27471098;Dbxref=PMID:27471098	
Q9BR39	UniProtKB	Natural variant	101	101	.	.	.	ID=VAR_065471;Note=In CMH17%3B modifies the secondary structure of the protein which is more flexible but does not undergo structural transition upon binding to membrane lipids%3B increases the affinity for phosphatidylserine%3B affects intracellular calcium handling and homeostasis. S->R;Ontology_term=ECO:0000269,ECO:0000269;evidence=ECO:0000269|PubMed:17509612,ECO:0000269|PubMed:24001019;Dbxref=PMID:17509612,PMID:24001019	
Q9BR39	UniProtKB	Natural variant	141	141	.	.	.	ID=VAR_065472;Note=In CMH17%3B results in vacuolization of intracellular structures and cardiomyocyte hypertrophy%3B affects intracellular calcium handling and homeostasis. Y->H;Ontology_term=ECO:0000269;evidence=ECO:0000269|PubMed:17509612;Dbxref=dbSNP:rs387906897,PMID:17509612	
Q9BR39	UniProtKB	Natural variant	161	161	.	.	.	ID=VAR_081288;Note=In CMH17. T->K;Ontology_term=ECO:0000269;evidence=ECO:0000269|PubMed:30235249;Dbxref=PMID:30235249	
Q9BR39	UniProtKB	Natural variant	165	165	.	.	.	ID=VAR_065473;Note=In CMH17%3B results in vacuolization of intracellular structures and cardiomyocyte hypertrophy%3B affects intracellular calcium handling and homeostasis. Greatly reduced phosphorylation. Increased myotube diameter. Reduced RYR1 activity and EC gain. Disruption of interaction with TRPC3. S->F;Ontology_term=ECO:0000269,ECO:0000269;evidence=ECO:0000269|PubMed:17509612,ECO:0000269|PubMed:20095964;Dbxref=dbSNP:rs387906898,PMID:17509612,PMID:20095964	
Q9BR39	UniProtKB	Natural variant	169	169	.	.	.	ID=VAR_081289;Note=Probable disease-associated mutation found in a patient with atrial fibrillation. E->K;Ontology_term=ECO:0000269;evidence=ECO:0000269|PubMed:23973696;Dbxref=PMID:23973696	
Q9BR39	UniProtKB	Natural variant	396	396	.	.	.	ID=VAR_053447;Note=A->T;Dbxref=dbSNP:rs3810510	
Q9BR39	UniProtKB	Natural variant	405	405	.	.	.	ID=VAR_081290;Note=In CMH17%3B unknown pathological significance. A->S;Ontology_term=ECO:0000269;evidence=ECO:0000269|PubMed:28393127;Dbxref=PMID:28393127	
Q9BR39	UniProtKB	Natural variant	436	436	.	.	.	ID=VAR_065474;Note=R->C;Ontology_term=ECO:0000269;evidence=ECO:0000269|PubMed:17476457;Dbxref=dbSNP:rs1326977511,PMID:17476457	
Q9BR39	UniProtKB	Natural variant	505	505	.	.	.	ID=VAR_065475;Note=In patients with cardiomyopathy%3B does not affect protein conformation as shown by circular dichroism%3B a patient with cardiomyopathy also carries V-26 and C-513 in MYH7. G->S;Ontology_term=ECO:0000269;evidence=ECO:0000269|PubMed:17476457;Dbxref=dbSNP:rs140740776,PMID:17476457	
